Ada Wierød

551 total citations
13 papers, 404 citations indexed

About

Ada Wierød is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Ada Wierød has authored 13 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 5 papers in Immunology and 3 papers in Hematology. Recurrent topics in Ada Wierød's work include Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (7 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Ada Wierød is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (12 papers), Spondyloarthritis Studies and Treatments (7 papers) and Psoriasis: Treatment and Pathogenesis (3 papers). Ada Wierød collaborates with scholars based in Norway, Netherlands and Poland. Ada Wierød's co-authors include Tore K Kvien, Erik Rødevand, S. Kalstad, Elisabeth Lie, Frode Krøll, Brigitte Michelsen, Hilde Berner Hammer, Eirik Klami Kristianslund, Glenn Haugeberg and K. M. Fagerli and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Seminars in Arthritis and Rheumatism.

In The Last Decade

Ada Wierød

12 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ada Wierød Norway 8 335 148 108 44 38 13 404
S. Kalstad Norway 11 596 1.8× 281 1.9× 289 2.7× 56 1.3× 53 1.4× 15 699
J. Kekow Germany 8 223 0.7× 118 0.8× 45 0.4× 60 1.4× 18 0.5× 13 332
K. M. Fagerli Norway 15 768 2.3× 302 2.0× 401 3.7× 83 1.9× 12 0.3× 41 866
K Sokoll United Kingdom 7 461 1.4× 187 1.3× 304 2.8× 51 1.2× 14 0.4× 11 536
Khaldoon Alawneh Jordan 12 97 0.3× 60 0.4× 48 0.4× 52 1.2× 31 0.8× 29 305
G. Terroso Portugal 8 135 0.4× 30 0.2× 41 0.4× 54 1.2× 8 0.2× 22 234
R. Ionescu Romania 12 127 0.4× 33 0.2× 74 0.7× 34 0.8× 14 0.4× 65 322
Frane Grubišić Croatia 11 155 0.5× 30 0.2× 72 0.7× 47 1.1× 7 0.2× 52 324
A. Ugarte Spain 8 260 0.8× 10 0.1× 109 1.0× 56 1.3× 29 0.8× 14 424
Gary L. Klipple United States 12 125 0.4× 35 0.2× 130 1.2× 69 1.6× 9 0.2× 15 390

Countries citing papers authored by Ada Wierød

Since Specialization
Citations

This map shows the geographic impact of Ada Wierød's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada Wierød with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada Wierød more than expected).

Fields of papers citing papers by Ada Wierød

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ada Wierød. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada Wierød. The network helps show where Ada Wierød may publish in the future.

Co-authorship network of co-authors of Ada Wierød

This figure shows the co-authorship network connecting the top 25 collaborators of Ada Wierød. A scholar is included among the top collaborators of Ada Wierød based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ada Wierød. Ada Wierød is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pripp, Are Hugo, Gunnstein Bakland, Bjørg‐Tilde Svanes Fevang, et al.. (2024). Comparative Effectiveness and Persistence of SB4 and Reference Etanercept in Patients With Psoriatic Arthritis in Norway. Arthritis Care & Research. 76(9). 1303–1312. 1 indexed citations
2.
Mielnik, Paweł, Joseph Sexton, K. M. Fagerli, et al.. (2023). Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD). Rheumatology Advances in Practice. 7(2). rkad053–rkad053. 1 indexed citations
3.
Lie, E., Joe Sexton, Ada Wierød, et al.. (2021). Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study. Scandinavian Journal of Rheumatology. 50(6). 445–454. 11 indexed citations
4.
5.
Michelsen, Brigitte, Joseph Sexton, Ada Wierød, et al.. (2019). Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study. Seminars in Arthritis and Rheumatism. 50(1). 12–16. 11 indexed citations
6.
Michelsen, Brigitte, Till Uhlig, Joseph Sexton, et al.. (2018). Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Annals of the Rheumatic Diseases. 77(9). 1290–1294. 22 indexed citations
7.
Sexton, Joseph, Eirik Klami Kristianslund, Inge Christoffer Olsen, et al.. (2018). Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study. RMD Open. 4(2). e000773–e000773. 7 indexed citations
8.
Michelsen, Brigitte, Eirik Klami Kristianslund, Joseph Sexton, et al.. (2017). Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Annals of the Rheumatic Diseases. 76(11). 1906–1910. 170 indexed citations
9.
10.
11.
Fagerli, K. M., D. van der Heijde, Marte Schrumpf Heiberg, et al.. (2014). Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study. Lara D. Veeken. 53(6). 1087–1094. 10 indexed citations
12.
Aga, Anna‐Birgitte, Elisabeth Lie, Till Uhlig, et al.. (2013). Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010. Annals of the Rheumatic Diseases. 74(2). 381–388. 127 indexed citations
13.
Fagerli, K. M., Désirée van der Heijde, Marte Schrumpf Heiberg, et al.. (2013). FRI0411 Response and drug survival of sulfasalazine in an observational study (nor-dmard) of dmard-naïve patients with axial spondyloarthritis (SPA). Annals of the Rheumatic Diseases. 72. A512–A513. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Kalstad Breakdown of academic impact, for papers by J. Kekow Breakdown of academic impact, for papers by K. M. Fagerli Breakdown of academic impact, for papers by K Sokoll Breakdown of academic impact, for papers by Khaldoon Alawneh Breakdown of academic impact, for papers by G. Terroso Breakdown of academic impact, for papers by R. Ionescu Breakdown of academic impact, for papers by Frane Grubišić Breakdown of academic impact, for papers by A. Ugarte Breakdown of academic impact, for papers by Gary L. Klipple
Rankless by CCL
2026